Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic obstructive pulmonary disease (COPD)
Pharma
FDA misses target date for GSK's Nucala in COPD
In the wake of mass restructuring efforts across the Department of Health and Human Services, the FDA has missed another approval decision target date.
Fraiser Kansteiner
May 8, 2025 1:39pm
Sanofi aims to grow Beyfortus after blockbuster sales year
Jan 30, 2025 11:45am
Verona's new COPD drug Ohtuvayre racked up sales of $42M in 2024
Jan 7, 2025 1:27pm
Amgen, AZ's Tezspire excels in phase 3 rhinosinusitis trial
Nov 8, 2024 3:31pm
AstraZeneca backs campaign to improve lives of COPD patients
Nov 4, 2024 10:40am
AstraZeneca's new TV spot for COPD drug Breztri sets sail
Oct 22, 2024 7:35am
